These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31677109)

  • 1. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.
    Coon C; Berger N; Eastwood D; Tsai S; Christians K; Mogal H; Clarke C; Gamblin TC
    Ann Surg Oncol; 2020 Apr; 27(4):1156-1163. PubMed ID: 31677109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.
    Liu C; Rein L; Clarke C; Mogal H; Tsai S; Christians KK; Gamblin TC
    J Surg Oncol; 2020 Aug; 122(2):176-182. PubMed ID: 32383268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
    Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
    Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.
    Wu L; Tsilimigras DI; Paredes AZ; Mehta R; Hyer JM; Merath K; Sahara K; Bagante F; Beal EW; Shen F; Pawlik TM
    World J Surg; 2019 Jul; 43(7):1777-1787. PubMed ID: 30820734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
    Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C
    Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
    Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
    Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
    HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function.
    Benjamin AJ; Baker TB; Talamonti MS; Bodzin AS; Schneider AB; Winschester DJ; Roggin KK; Bentrem DJ; Suss NR; Baker MS
    Surgery; 2018 Mar; 163(3):582-586. PubMed ID: 29370929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
    Groeschl RT; Turaga KK; Gamblin TC
    J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
    Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
    J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of Minimally Invasive Liver Resection for Primary Malignancy: Reevaluating Effectiveness.
    Varley PR; Tohme ST; Chidi AP; Goswami J; van der Windt D; Geller DA; Tsung A
    Ann Surg Oncol; 2018 Mar; 25(3):808-817. PubMed ID: 29302818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.
    Lee JW; Lee YJ; Park KM; Hwang DW; Lee JH; Song KB
    World J Surg; 2016 Jun; 40(6):1429-39. PubMed ID: 26817652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
    Donadon M; Terrone A; Procopio F; Cimino M; Palmisano A; Viganò L; Del Fabbro D; Di Tommaso L; Torzilli G
    Surgery; 2019 May; 165(5):897-904. PubMed ID: 30691871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of marginal resection for hepatocellular carcinoma.
    Kobayashi N; Aramaki O; Midorikawa Y; Higaki T; Nakayama H; Moriguchi M; Takayama T
    Surg Today; 2020 Nov; 50(11):1471-1479. PubMed ID: 32472316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.